Leadership Overview
Proxima Research International has 6 executives leading key functions including strategy, technology, information systems, revenue growth, financial management, and human resources.
Focused on advancing pharmaceutical intelligence, Proxima Research International delivers data-driven solutions to optimize market access and clinical research outcomes across global healthcare sectors.
Focused on advancing pharmaceutical intelligence, Proxima Research International delivers data-driven solutions to optimize market access and clinical research outcomes across global healthcare sectors.
Leadership Roles at Proxima Research International
Oleksandr Khraban - Chief Executive Officer
Oleksandr Khraban, the Chief Executive Officer at Proxima Research International, directs the overarching corporate strategy and long-term vision for the organization. By aligning internal resources with the evolving needs of the global pharmaceutical industry, the Chief Executive Officer ensures consistent market relevance and operational excellence. This leadership role involves constant engagement with the Board to refine business models and expand the footprint of the company across international markets. Oleksandr Khraban maintains a sharp focus on driving sustainable growth while navigating complex regulatory landscapes. Through the implementation of high-level performance metrics, the Chief Executive Officer fosters a culture of accountability and innovation. Ultimately, the executive secures the competitive position of the firm by anticipating industry shifts and prioritizing the delivery of high-value data insights to clients worldwide, thereby cementing the reputation of the organization as a leader in pharmaceutical intelligence.
Oleksii Bedun - Group Chief Financial Officer
Oleksii Bedun, the Group Chief Financial Officer at Proxima Research International, oversees the financial health and fiscal planning of the entire organization. By managing capital allocation, budgeting, and financial reporting, the Group Chief Financial Officer ensures that the company maintains the necessary resources to support its strategic growth initiatives. This role involves conducting detailed financial analysis to identify risks and opportunities within the global pharmaceutical market. Oleksii Bedun directs the financial operations that underpin the stability and long-term viability of the firm. Through close collaboration with the executive team, the Group Chief Financial Officer provides the insights required to make informed investment decisions and optimize operational costs. This leadership function guarantees that the financial structure of the company remains resilient, allowing for continued investment in research capabilities and the expansion of service offerings across international markets.
Dmitriy Dorosh - Chief Technology Officer
Dmitriy Dorosh, the Chief Technology Officer at Proxima Research International, architects the technical infrastructure required to support advanced pharmaceutical data analytics. Overseeing the development of proprietary software platforms, the Chief Technology Officer ensures that all digital tools meet the rigorous demands of modern clinical research and market analysis. This role involves managing engineering teams to accelerate product deployment and enhance system scalability across diverse geographic regions. Dmitriy Dorosh drives the integration of emerging technologies to maintain a technological edge in a competitive industry. By collaborating closely with other C-suite leaders, the Chief Technology Officer aligns technical roadmaps with the broader business objectives of the company. This strategic oversight guarantees that the technological foundation remains robust, secure, and capable of processing massive datasets, which directly supports the ability of the firm to provide actionable insights to pharmaceutical partners globally.
Artem Andrushchenko - Chief Information Officer
Artem Andrushchenko, the Chief Information Officer at Proxima Research International, manages the integrity, security, and accessibility of critical data assets. By implementing sophisticated information governance frameworks, the Chief Information Officer ensures that all internal systems comply with international data protection standards while facilitating seamless information flow across departments. This leadership role involves optimizing data architecture to support the complex analytical requirements of the pharmaceutical sector. Artem Andrushchenko directs the digital transformation initiatives that improve operational efficiency and decision-making capabilities. Through the oversight of enterprise-wide information systems, the Chief Information Officer enables the organization to leverage data as a primary competitive advantage. This focus on information excellence allows the company to maintain high standards of accuracy and reliability, which remains essential for supporting the research and development activities of clients operating within the highly regulated global pharmaceutical landscape.
Roman Shovkun - Chief Revenue Officer (USA)
Roman Shovkun, the Chief Revenue Officer (USA) at Proxima Research International, drives the commercial strategy and sales expansion efforts within the North American market. By identifying new business opportunities and cultivating relationships with key pharmaceutical stakeholders, the Chief Revenue Officer (USA) ensures consistent revenue growth and market penetration. This role involves designing effective pricing models and go-to-market strategies that align with the specific needs of the regional healthcare industry. Roman Shovkun coordinates with marketing and product teams to maximize the impact of service offerings and increase client retention. Through the rigorous analysis of sales performance data, the Chief Revenue Officer (USA) optimizes the revenue funnel and improves overall profitability. This leadership position remains vital for establishing a strong presence in the United States, ensuring that the company effectively captures market share while delivering exceptional value to every client partner.
Anatolii Shapovalov - Chief Human Resources Officer
Anatolii Shapovalov, the Chief Human Resources Officer at Proxima Research International, directs the talent acquisition, employee development, and organizational culture initiatives. By fostering a high-performance environment, the Chief Human Resources Officer ensures that the company attracts and retains the specialized expertise required to excel in the pharmaceutical intelligence sector. This role involves designing comprehensive training programs and performance management systems that align individual contributions with the broader mission of the organization. Anatolii Shapovalov oversees the implementation of human capital strategies that support the scaling of operations across diverse global regions. Through the promotion of professional growth and employee engagement, the Chief Human Resources Officer builds a workforce capable of meeting the complex demands of the industry. This leadership role remains essential for maintaining the competitive advantage of the firm by ensuring that the right talent is positioned to drive innovation and operational success.
Explore Leadership Teams in Manufacturing
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The company invests heavily in research and development, maintaining a robust pipeline of innovative medicines and diagnostic solutions while collaborating with academic institutions, biotechnology companies, and healthcare partners worldwide. Headquartered in Basel, Switzerland, Roche operates globally with a presence in numerous countries, employing a diverse workforce of scientists, researchers, healthcare professionals, and business experts dedicated to transforming patient care and making a meaningful difference in the fight against serious diseases.
Company Leadership CB

JC
Sun Pharma is a specialty generic pharmaceutical company that manufactures and distributes pharmaceutical formulations and active pharmaceutical ingredients. It is heaquartered in Mumbia, India. Sun Pharma is a global pharmaceutical company that develops, manufactures, and markets specialty medicines, generic drugs, complex generics, and active pharmaceutical ingredients. Its primary industry is pharmaceutical manufacturing, with pharmaceutical research and development as a secondary activity.
Company Leadership JG
GS
MP
Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership


TS
Headquartered in Woodbury, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery.
Company Leadership DS

BS